Goldline Pharmaceutical Ltd Market Cap

Market Capitalization of Goldline Pharmaceutical Ltd

Image

Goldline Pharmaceutical Ltd

NSE: GLPL

Market Cap

₹ 51.78 crore

Last updated on: May 20, 2026

Key Highlights

  • The Market Cap of Goldline Pharmaceutical Ltd is ₹ 51.78 crore as of 20 May 26 The Latest Trading Price of Goldline Pharmaceutical Ltd is ₹ 53.94 as of 20 May 15:30 .
Image

Goldline Pharmaceutical Ltd

NSE: GLPL

Share Price

₹ 53.94

-2.83 (-4.99%)

stock direction

Last updated on: May 20, 2026

Market Price of Goldline Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Goldline Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 May 202653.94
19 May 202656.77

BlinkX Score for Goldline Pharmaceutical Ltd

Asset Value vs Market Value of Goldline Pharmaceutical Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Goldline Pharmaceutical Ltd

No data available

Historical P/E Ratio of Goldline Pharmaceutical Ltd

No data available

* All values are in %

Historical Revenue of Goldline Pharmaceutical Ltd

No data available

* All values are in crore

Historical EBITDA of Goldline Pharmaceutical Ltd

No data available

* All values are in crore

Historical Net Profit of Goldline Pharmaceutical Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Goldline Pharmaceutical Ltd

  • Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai.
  • Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f.
  • September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
  • Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente.
  • The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company.

Goldline Pharmaceutical Ltd News Hub

BSE SME Goldline Pharmaceutical delivers a dose of listing gains

The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc

Read more

19 May 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for null Market Cap

What is the market cap of Goldline Pharmaceutical Ltd?

As of May 20, 2026, Goldline Pharmaceutical Ltd has a market capitalization of ₹51.78, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Goldline Pharmaceutical Ltd's market capitalization?

Goldline Pharmaceutical Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Goldline Pharmaceutical Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Goldline Pharmaceutical Ltd's market capitalization change?

Goldline Pharmaceutical Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions